Making cardiac monitoring
accessible to everyone
We believe that early detection of cardiac anomalies should not depend on geography, income, or access to specialized care. CardioGuard brings clinical-grade AI monitoring to every patient, anywhere in the world.
Prevent cardiac emergencies
before they happen
Every year, millions of cardiac events go undetected until it's too late. CardioGuard was founded with a single mission: use artificial intelligence to bridge the gap between wearable data and clinical decision-making.
Our platform combines continuous ECG monitoring from consumer and medical-grade wearable devices with MedGemma — Google's multimodal clinical AI — to detect arrhythmias, ST-segment changes, and other anomalies in real-time.
Clinical intelligence you can trust
MedGemma is Google's family of open medical AI models built for healthcare applications. CardioGuard leverages MedGemma's multimodal capabilities to analyze ECG waveforms, patient history, and contextual data — delivering clinically actionable insights with 99.2% anomaly detection accuracy.
Built on principles that matter
Patient First
Every design decision prioritizes patient safety and comprehension. Clinical data presented in human-understandable language.
Clinical Rigor
Built to healthcare standards. HIPAA compliant, GDPR ready, and designed for FDA pathway clearance.
Global Access
Cardiac monitoring shouldn't be a privilege. We're building for worldwide accessibility across devices and networks.
AI Transparency
Our AI explains its reasoning. Every alert includes clinical context so physicians can validate findings independently.
Clinicians, engineers, and researchers
A multidisciplinary team united by a shared belief that technology can save lives when built with clinical expertise.
Dr. Emily Zhao
Chief Medical Officer
Alex Rivera
CEO & Co-founder
Dr. Raj Malhotra
Head of AI Research
Sarah Lindqvist
VP of Engineering